skip to log on skip to main content

How will coronavirus affect investments?

19 February 2020

House view

 

 

 

 

 

As the coronavirus emergency continues, economists and investors are assessing the financial impact of the disease and measures put in place to curb its spread.

Coronavirus was first reported in the city of Wuhan, China on December 31, 2019, and has so far infected more than 70,500 people worldwide and resulted in more than 1700 deaths, according to the World Health Organisation

Entire cities are under quarantine in mainland China, where most of the cases have occurred, while businesses and transport networks across the country have been shut down in efforts to contain the virulent infection.

Other countries have also responded, restricting travel to and from China, imposing local quarantines, and tracking local cases.

The controls are already harming industries such as education, luxury products, air travel and tourism. Global supply chains are taking a hit with factory stoppages disrupting the availability of products and components manufactured in China.

China’s top medical expert on coronavirus, Zhong Nansha, told Reuters the disease could peak by late February and end by April, with the number of new reported cases already declining in some areas - although there’s little consensus among other experts on when the disease will be stopped.

Navigate turbulent times with confidence

Speak to us today

Financial reactions

The timing of the outbreak poses a risk to the investment cycle, says ANZ chief investment officer Mark Rider.

“Before the coronavirus hit, the global economy looked to post at best a moderate recovery from the slowdown of the past couple of years, with fallout from the US-China trade dispute still evident,” Rider says.

“For Australia the economic environment is also complicated by the fallout from the bushfires over the past couple of months. And all of this has come on top of markets that are looking stretched with valuations typically at rich levels.”

Financial markets reacted quickly to the outbreak. The Shanghai Composite Index fell 7.7 per cent when the market reopened on February 3 after the Lunar New Year holiday, which was extended by three days in an attempt to combat the virus.

News of the outbreak caused the US S&P 500 to lose most of the 3.1 per cent gain it made in the first three weeks of the year. (The index has since recovered and is trading at new highs.)

The Australian dollar fell, although Australia’s share market has been resilient, with the S&P/ASX 200 up 6.67 per cent in the year to mid-February.

“Clearly there’s a real economic and market impact in the short term but these types of events tend to be transient in markets,” says ANZ Private financial planning director David Lipari.

History lessons

Experience from the SARS outbreak in 2002-03 shows such events tend to have short-lived effects on financial markets and economic growth, says Rider.

SARS first appeared in November 2002 and stopped in July 2003, according to the World Health Organisation. In that time, there were more than 8400 cases, resulting in just over 800 deaths.

“The Hang Seng based around the peak of new [SARS] infections before recovering in subsequent months. Similar patterns were evident in other major share markets,” Rider says.

Economic growth in China also bounced back quickly after a sharp fall due to SARS. Annualised gross domestic product (GDP) growth rates dropped to 3.4 per cent in the second quarter of 2003 from 12.2 per cent in the first quarter, before recovering to 15.7 per cent in quarter three, Chinese Bureau of Statistics data shows

What next?

Rider says it’s too early to say what the full impact of the current coronavirus epidemic will be, but he warns it may have greater economic consequences than the 2002-03 SARS epidemic as China is now more important to the global economy.

“For Australia, the dependency on China has risen sharply with over a third of goods exports now destined for China, a five-fold increase. The share of Chinese tourists has risen by a similar magnitude to 16 per cent of total short-term arrivals and now accounts for 27 per cent of total visitor expenditure,” Rider says

ANZ’s latest estimate, in mid-February, was that China’s first quarter GDP would likely slow to 3.2-4 per cent. This is lower than ANZ’s initial projection of 5 per cent based on an assumption of a shorter spell of interruption.

“In Australia the hit is estimated to be 0.5 per cent of GDP in 2020, in contrast with only a 0.07 per cent impact from the SARS epidemic,” Rider says.

This anticipated blip shouldn’t change investors’ approach to their portfolios.

ANZ’s investment managers had already moderately reduced risk in their discretionary diversified portfolios before the coronavirus outbreak really took hold. On the back of ample liquidity, improving investor sentiment and a basing in the global industry cycle, they believe equities have run too far ahead of fundamentals.

The managers reduced their exposure to growth assets, particularly global developed market equities and hedged international shares to provide a more defensive positioning for the portfolios.

“Within defensive assets we took the portfolios to long duration, with global fixed income moved from benchmark to overweight with duration providing diversification,” Rider says.

Similarly, with share markets currently appearing fully priced, investors should display caution says Lipari.

“We’re certainly happy to own share market assets on a longer term basis but we don’t currently see short-term events here as presenting a significant buying opportunity… Undoubtedly some opportunities may arise but our focus remains on seeking to acquire high-quality assets for the long term.”

 

Read the recent China Insight and Australian Economic Insight articles from ANZ Research.

 

 

To discuss what this insight could mean for you, talk to your ANZ Private Banker directly, or contact us below

You might also like

Need for caution following new year record rally

24 January 2020

INVESTMENT

While short terms risks are present, we maintain a constructive 12-month view on equities, explains Mark Rider

 

Read more

ANZ global market outlook 2020: recovery in sight

19 December 2019

INVESTMENT

Mark Rider explains that investors should expect a slow and tenuous resurgence in the economy and markets.

 

Read more

Sharemarket hopes depend on US-China deal

13 December 2019

INVESTMENT

Mark Rider explains the tensions at work in the global economy and what investors can expect.

 

Read more

Contact us

Request a call back

Provide your details and we'll call when it suits you

Request a call back

   

Email ANZ Private

Email us with your query and we'll reply to you directly.

Send an email

Call us

Speak to the ANZ Private team directly

1800 316 926

We're available weekdays 9:00am to 6:00pm AEST

Find an ANZ Private office

Our locations across Australia

Find an office

ANZ Private Bankers are representatives of Australia and New Zealand Banking Group Limited ABN 11 005 357 522 (ANZ), the holder of Australian Financial Services Licence number 234527. This document ("document") is distributed to you by ANZ and may not be reproduced, distributed or published by any recipient for any purpose.

The information provided is general in nature only and does not take into account your personal objectives, financial situation or needs. Please consider its appropriateness to you before making any investment decisions. It should not be relied upon as a substitute for professional advice. For any product referred to above, ANZ recommends that you read any relevant offer document or product disclosure statement and consider if the product is appropriate for you. For products issued by ANZ, these documents are available at www.anz.com. This document is current as at the date of this publication but is subject to change. The document is provided and issued by ANZ unless another author is specified in the document, in which case it is provided and issued by that author. The views expressed are those of the authors only and do not necessarily reflect the opinions or views of ANZ, its employees or directors. Whilst care has been taken in preparing this document, ANZ and its related entities do not warrant or represent that the document is accurate or complete. To the extent permitted by law, ANZ and its related entities do not accept any responsibility or liability from the use of the information. Past performance is not indicative of future performance and any case study shown is for illustrative purposes only. Neither are a prediction of the actual outcome which will be achieved. Some of this information may have tax implications. We recommend that you seek specialist tax advice on how it may impact your tax obligations, liabilities or entitlements.